Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,642.50
+8.90 (0.54%)
Aug 14, 2025, 3:29 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 171.83 billion as of August 15, 2025. Its market cap has decreased by -0.18% in one year.
Market Cap
171.83B
Enterprise Value
168.68B
Revenue
11.88B
Ranking
n/a
PE Ratio
48.27
Stock Price
1,642.50
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 171.83B, an increase of 74.22%. That is a compound annual growth rate of 32.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 171.83B | -25.70% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,934.43B |
| Divi's Laboratories | 1,619.49B |
| Cipla | 1,260.90B |
| Apollo Hospitals Enterprise | 1,122.74B |
| Mankind Pharma | 1,017.79B |
| Zydus Lifesciences | 994.76B |
| Fortis Healthcare | 714.04B |
| Alkem Laboratories | 644.28B |